First human trial tests brain stem cell injection for Parkinson's
NCT ID NCT02452723
Summary
This early-stage study tested whether injecting human neural stem cells into specific brain areas is safe for people with moderate to severe Parkinson's disease. Twelve participants received one of three different doses of the experimental cell therapy. The main goal was to check for side effects and see if the treatment was well-tolerated.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dept of Neurology, The Royal Melbourne Hospital
Melbourne, Victoria, 3050, Australia
Conditions
Explore the condition pages connected to this study.